The time course of four EEG effect variables, amplitude in the 2±5 Hz and in the 11±15 Hz band, spectral edge frequency 95% (SEF95), and bispectral index (BIS), in response to increasing concentrations of thiopental, propofol, etomidate, midazolam, or sevo¯urane during a 10 min induction of anaesthesia was studied in 25 patients to determine the existence of a biphasic effect and to study the relationship of the EEG effect to the moment of loss of consciousness. A biphasic effect, that is, an initial increase of the effect variable followed by a decrease at higher concentrations, during the transition from consciousness to unconsciousness was found in EEG amplitude (both frequency bands) and in SEF95 for all anaesthetics except midazolam. There was a concentration-related decrease in BIS for all anaesthetics. There was no consistent relationship between the time of occurrence of the peak EEG effect, or the value of the EEG variable and the moment of loss of consciousness. With rapidly changing drug concentrations during the induction of anaesthesia, none of these EEG effect variables could be correlated to the moment of loss of consciousness. Processed EEG variables recorded during anaesthesia usually decrease with increasing drug concentrations. However, during the transition from consciousness to unconsciousness, using induction agents, many derived EEG variables show biphasic effects, that is an initial increase of the effect variable followed by a decrease at higher concentrations. This has been observed with thiopental, 1 propofol, 2 3 and sevo¯urane. 4 For etomidate, a biphasic effect was described in animals. 5 Midazolam does not appear to induce biphasic EEG changes. 6 The moment of loss of consciousness seems to be related to the occurrence of a maximum effect of the EEG variable, at least when propofol, thiopental, or sevo¯urane are used to induce anaesthesia. For the other drugs such a relationship has not been demonstrated. If a biphasic relationship exists for all hypnotic agents, then the reappearance of a maximum EEG height might be used as an indicator of imminent awareness.
Processed EEG variables recorded during anaesthesia usually decrease with increasing drug concentrations. However, during the transition from consciousness to unconsciousness, using induction agents, many derived EEG variables show biphasic effects, that is an initial increase of the effect variable followed by a decrease at higher concentrations. This has been observed with thiopental, 1 propofol, 2 3 and sevo¯urane. 4 For etomidate, a biphasic effect was described in animals. 5 Midazolam does not appear to induce biphasic EEG changes. 6 The moment of loss of consciousness seems to be related to the occurrence of a maximum effect of the EEG variable, at least when propofol, thiopental, or sevo¯urane are used to induce anaesthesia. For the other drugs such a relationship has not been demonstrated. If a biphasic relationship exists for all hypnotic agents, then the reappearance of a maximum EEG height might be used as an indicator of imminent awareness.
We therefore studied the behaviour of four different EEG effect variables during slow induction of anaesthesia with thiopental, propofol, etomidate, midazolam, or sevo¯urane with the aims of determining whether a biphasic EEG response was present, and to assess the time to the maximum EEG effect, the times of loss of consciousness, and the relationship between these variables for each study drug. The following variables were analysed: EEG amplitude in two frequency bands, spectral edge frequency 95%, and the bispectral index (BIS), a proprietary composite EEG effect variable designed to have no biphasic response pattern.
Patients with a history of recent intake of drugs that might affect the EEG, an alcohol intake in excess of 30 g day ±1 , neurological disorders, extreme nervousness, or a contraindication for one of the study drugs were excluded. No oral intake was allowed after midnight preceding the day of surgery. No pre-medication was administered.
After arrival in the anaesthetic room, an i.v. cannula was inserted and 0.9% saline 500 ml was infused rapidly for uid loading. Patients were monitored with a three-lead ECG, Sp O 2 , and non-invasive arterial pressure measurements performed at 1-min intervals. Each experiment took place before the start of surgery and lasted 15 min. The study period was divided into a 3 min baseline EEG recording, a 10 min duration EEG recording during study drug administration, and was followed by a 2 min EEG recording without drug administration. The calculation of the dose body weight, corrected for height, was: height (cm)±100=kg body weight. The patients were randomly assigned to one of ®ve groups to receive a 10 min constant rate infusion of thiopental 1 mg kg ±1 min ±1 , propofol 0.5 mg kg ±1 min ±1 , etomidate 0.06 mg kg ±1 min ±1 , midazolam 0.03 mg kg ±1 min ±1 , or sevo¯urane in oxygen enriched air administered by a circle system with a fresh gas ow of 9 litre min ±1 and facemask. The sevo¯urane concentration of the fresh gas was initially set at 2% and increased every minute by an additional 2% to a maximum of 8%. The last concentration was maintained for a further 7 min. With this dosing regimen we aimed to induce a steadily increasing blood and CNS concentration (Fig. 1) .
If spontaneous ventilation became insuf®cient as indicated by Sp O 2 below 92% or signs of upper airway obstruction, a free airway was re-instituted by chin lift and if necessary ventilation was assisted by facemask and oxygen enriched air (40%) to maintain E¢ CO 2 between 4.5 and 6.0 kPa.
EEG was recorded from Cz-Fpz and the M2 (right mastoid)-Fpz2 with an electrode placed between Fpz and Fpz2 as reference. All signals were recorded with the patients in the supine position and eyes closed. The analogue EEG was recorded using the pre-ampli®ers of the Lifescan EEG monitor and stored on tape for off-line analysis. For calculation of EEG amplitude in the 0±5 and 11±20 Hz band we used aperiodic analysis 7 (Lifescan, software version 4.3, Diatek, San Diego, CA, USA). For calculation of BIS 8 and spectral edge frequency 95% (SEF95) values we used the Aspect A-1000 EEG monitor (BIS version 3.12: Aspect Medical Systems Inc., Natick, MA, USA). EEG amplitudes in the two frequency bands were calculated from 10-s epochs. Epochs containing an EEG amplitude greater than 30 mV in the 25±30 Hz band were considered to contain too many artefacts and were rejected. The Aspect A1000 low pass ®lter was set at 30 Hz, the high pass ®lter was set to 2 Hz. Periods containing artefacts, as indicated by the Aspect A1000 were rejected. Spectral edge smoothing was set at 10 s and BIS smoothing at 15 s. No correction was made for the internal 60 s smoothing of the BIS 3.12. Thus, amplitude and SEF95 data represent EEG data of the preceding 10 s. BIS data represent data from the preceding 75 s.
Responsiveness was determined by testing the response of the patient to simple commands from a pre-recorded tape (`raise your thumb',`spread your ®ngers', and`clench your ®st'), given by headphones every 30 s. The ®rst time that the patient did not respond to a verbal command was registered 
De®nitions and statistical analysis
The EEG response to increasing blood concentrations was considered biphasic if after the start of the drug administration the EEG effect variable increased at least 2 SD above baseline value and, thereafter, decreased 20% below that maximum value.
The patient was supposed to have lost consciousness at the moment of the maximum change of the EEG variable if the moment of LR was less than 30 s different from it.
Data are presented as median and range. EEG data were compared using the Kruskal-Wallis test. P<0.05 was considered signi®cant.
Results
Physical characteristics of the patients and the moments of LR are presented in Table 1 . EEG data from the Fpz-Cz leads during the infusion showed a similar time course compared with the EEG data from the Fpz2-M2 leads. But EEG data derived from the Fpz2-M2 leads showed more variability than EEG data derived from the FPz-Cz leads during the baseline recording before drug administration. We therefore decided to present only data from the Fpz-Cz leads.
During the administration of thiopental, propofol, etomidate, and sevo¯urane the EEG of the patients showed an increase of alpha and beta activity followed by an increase of delta activity and a decrease of beta and alpha activity. All patients in the propofol and etomidate groups and most of the patients in the thiopental group showed a decrease in delta activity by end of the infusion. In the sevo¯urane patients, delta activity initially decreased after the maximal effect but did not decrease further despite continued administration. Increasing midazolam doses resulted in increased beta activity.
The EEG amplitude in both frequency bands and SEF95 showed biphasic effects for all drugs except midazolam. The BIS value decreased for all drugs ( We did not observe a consistent relationship between the moment of LR and the moment of occurrence of a peak EEG effect. The value of the EEG effect at the moment of LR showed a large variability between patients. BIS values at the moment of LR were signi®cantly higher in the sevo¯urane group than in all other groups ( Table 2) . 
Discussion
In this study we demonstrated biphasic EEG effects for all the induction agents except for midazolam. Biphasic effects, that is an increase in alpha and beta activity followed by a decrease in alpha and beta activity and a simultaneous increase in delta activity have been observed in the analogue EEG. 9 10 Veselis and co-workers have shown that EEG power in the beta band increases with increasing blood concentrations of thiopental, propofol, and midazolam.
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They did not observe a decrease of EEG power, but as the drugs were administered in sedative doses only, their patients did not lose consciousness. Other investigators have shown that SEF95 and median frequency decrease when depth of anaesthesia increases. 12±14 Therefore, a peak change in EEG amplitude in the higher frequency bands during the transition from sedation to unconsciousness is very likely. Such biphasic effects have been described for thiopental, 15 propofol, 16 and more recently for sevo¯urane. 4 The occurrence of a short-lived peak effect on the EEG might be a marker for the transitional state between consciousness and unconsciousness. If consciousness is lost before the peak change in EEG occurs, that is at a lower blood concentration, during decreasing concentrations a peak EEG effect is coupled with a risk of imminent awareness. Although we observed biphasic effects for all drugs except midazolam during increasing drug concentrations, loss of consciousness did not occur consistently before the maximum change in these EEG variables. This ®nding limits the potential application of the occurrence of a peak EEG effect to predict imminent awareness. The actual EEG amplitudes and SEF95 values at which consciousness was lost showed a large inter-individual variability. Therefore, absolute values of EEG derived variables are not reliable indicators of loss of consciousness either. One explanation for the absence of a consistent correlation between the time to loss of consciousness and the value of the EEG effect variable or the time to peak EEG effect for the ®ve drugs might be the biphasic response of the EEG variables to increasing blood concentrations. Such a biphasic response may be the result of simultaneous drug effects both on systems that cause EEG activation and on systems that cause EEG suppression. At lower concentrations, activation is more pronounced than suppression, which results in an increase of amplitude at higher frequencies. At higher concentrations the suppression becomes more evident which results in a decrease of amplitude at higher frequencies and eventually in a decrease of EEG amplitude at lower frequencies. All ®ve drugs suppress consciousness in a dose dependent way. Midazolam does not induce a biphasic EEG response and consciousness was lost before maximal beta activity was reached. With the other drugs one might expect that consciousness would be lost when EEG activity was still increasing in a similar way to midazolam. However, EEG suppression at low concentrations might have counteracted the activation to such an extent that EEG activity had already started to decrease before consciousness was lost. As all drugs have different chemical structures it is likely that there will be differences in the balance of effects on activation and suppression. Therefore, such differences will result in differences in EEG effects at the moment of loss of consciousness.
BIS has been used successfully as an indicator of the level of sedation and hypnosis. 17 18 In the present study we observed that consciousness in the sevo¯urane group was lost at higher BIS values than in the other groups (Table 2) . This might be caused by the steep decrease in BIS during induction. As a result of the long period over which BIS 3.12 calculates its value, for example, 60+15 s smoothing, the actual BIS value will be overestimated if BIS decreases rapidly. More recent software versions with a shorter calculation epoch may overcome this problem. Another explanation for the higher BIS values observed at the time of LR might be because of the non-speci®c mechanism of action of sevo¯urane inducing loss of consciousness at lower levels of cortical suppression. In a study in which semisteady state concentrations of sevo¯urane were applied, 4 a method that will effectively eliminate averaging effects, the average BIS for preventing response to verbal command was 73. This value is similar to the values found for midazolam, thiopental, propofol, and etomidate in our study. This ®nding makes the ®rst explanation for the higher BIS values at loss of responsiveness for sevo¯urane more likely.
A drawback of the present study is the lack of EEG data during return of consciousness. EEG values at return of consciousness might be different from the EEG values at loss of consciousness and variability might be less. More gradual concentration changes during emergence from anaesthesia will decrease inaccuracy in determination of EEG effect and the determination of the moment of return of consciousness will be less critical. However, other investigators 19 have already indicated that during repeated transitions from unconsciousness to consciousness as the result of repeated interruptions of propofol administration to patients under spinal analgesia, neither SEF95 nor BIS are accurate indicators of imminent awareness.
We conclude that thiopental, propofol, etomidate, and sevo¯urane, but not midazolam induce biphasic EEG effects during the transition from consciousness to unconsciousness. There is no consistent time relationship between the peak EEG effect and the moment of LR. In the BIS algorithm, the biphasic response has been linearized effectively, resulting in a progressive decrease of BIS during progressively increasing hypnotic drug concentrations. Both the large inter-subject variability in the values of EEG amplitude and spectral edge, and the relatively long averaging period of BIS, limit the applicability of these variables as markers for imminent consciousness.
